Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P15088 (mast cell)
 14,925 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Skin biopsies from 13 Shar Peis showing signs of cutaneous mucinosis and 13 control dogs of different breeds with no clinical or histological evidence of skin disease were examined. One section of each tissue sample was stained with haematoxylin and eosin, and another with toluidine blue to demonstrate the sulphated acid glycosaminoglycans in mast cell (MC) granules. To investigate the MC subtypes involved, the tryptase and chymase content of mast cells was evaluated by a double enzyme-immunohistochemical staining technique. Regardless of the staining technique, a significantly lower mast cell density in the skin of Shar Peis was demonstrated. In the dermis of control dogs, we detected a median mast cell density of 31.2 MC/mm2 using the toluidine blue staining method and 27.5 MC/mm2 using the double labelling technique. In Shar Peis only 9.1 MC/mm2 were found by toluidine blue staining (P = 0.001) and 14.8 MC/mm2 by the double labelling method (P = 0.0387). The percentile distribution of mast cell subtypes was also significantly different in Shar Peis as compared to control dogs. Whereas in the dermis of control dogs the predominant mast cell subtype was the tryptase and chymase containing MC (TC-MC) (60.4%), in Shar Pei skin the only chymase containing MC (C-MC) predominated (62.2%) and the percentage of TC-MC was significantly lower (32.9%; P = 0.0016). The percentage of only tryptase containing MC (T-MC) (4.7%) was higher in Shar Peis compared to control dogs (1.9% P = 0.0178). The data obtained indicate a possible involvement of mast cell subtypes in the pathogenesis of cutaneous mucinosis. Further investigations on the pathophysiological role of mast cell subtypes may foster understanding of the pathogenesis of cutaneous mucinosis.
 ...
PMID:Mast cell density and subtypes in the skin of Shar Pei dogs with cutaneous mucinosis. 1044 5

A 7-year-old shar-pei was presented because of a recurrent dermatologic condition. Skin biopsies revealed an idiopathic (primary) cutaneous mucinosis that initially responded to corticosteroids. The condition reappeared 2 years later and subsequent biopsies revealed a mast cell tumor in some of the skin sites previously diagnosed with mucinosis.
 ...
PMID:Cutaneous mucinosis and mastocytosis in a shar-pei. 1064 65

Recent studies have suggested that mast cell numbers are increased in the skin of patients with cutaneous mucinosis and that these cells may have an important role in angiogenesis and production of mucin. Then, skin biopsies from 30 patients with cutaneous mucinosis (papular mucinosis, focal mucinosis, and mucinosis associated with lupus erythematosus) and from 10 healthy subjects were analyzed. Mast cells and blood vessels were immunolabeled with anti-tryptase and anti-CD34 antibodies, respectively, and then quantified stereologically. Counting was performed in papillary and reticular dermis. An increase in the number of mast cells was observed in the skin of patients with cutaneous mucinosis compared with the control group. Only minimal differences were observed in vessel stereology. There was no correlation between the increase in the number of mast cells and the number of blood vessels in the patients studied. There was no significant difference in the numbers of mast cells or blood vessels between the 3 subgroups of cutaneous mucinosis. Although many clinical forms of mucinosis have been described, neither mast cell number nor vessel distribution seems to distinguish the 3 different forms studied here.
 ...
PMID:Quantification of mast cells and blood vessels in the skin of patients with cutaneous mucinosis. 2044 41